Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study

Cutland, Clare; Nolan, Terry; Halperin, Scott; Kurugol, Z.; Ahmed, Khatija; Perrett, Kirsten; Richmond, Peter; Marshall, Helen; CEYHAN, MEHMET; Kolhe, Devayani; Hezareh, Marjan; Van Der Wielen, Marie

doi:10.1016/j.vaccine.2018.02.013

Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study

Copy For Citation

Cutland C. L., Nolan T., Halperin S. A., Kurugol Z. A., Ahmed K., Perrett K. P., ...More

VACCINE, vol.36, no.14, pp.1908-1916, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 36 Issue: 14
Publication Date: 2018
Doi Number: 10.1016/j.vaccine.2018.02.013
Journal Name: VACCINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1908-1916
Hacettepe University Affiliated: Yes

Abstract

Background: We evaluated the immunogenicity and safety of 1 and 2 doses of quadrivalent meningococcal serogroup A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-IT) given alone or co administered with 13-valent pneumococcal conjugate vaccine (PCV13) in toddlers.